A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

Chi, Hsin

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan. [electronic resource] - PloS one 2014 - e100981 p. digital

Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

1932-6203

10.1371/journal.pone.0100981 doi


Antibodies, Monoclonal, Humanized--administration & dosage
Antiviral Agents--administration & dosage
Chemoprevention--methods
Drug Administration Schedule
Female
Humans
Infant, Newborn
Infant, Premature
Male
Palivizumab
Respiratory Syncytial Virus Infections--drug therapy
Risk Factors